Searching journal content for articles similar to Foulkes et al. 24 (3): R35.

Displaying results 1-10 of 761
For checked items
  1. Review:
    • Nicholas Russell,
    • Ada Cheung,
    • and Mathis Grossmann
    Estradiol for the mitigation of adverse effects of androgen deprivation therapy Endocr Relat Cancer 24 (8) R297-R313, doi:10.1530/ERC-17-0153 first published on 30 June 2017
    ...indexed on the PubMed database from 1940 to May 24, 2017, using the following search terms: prostate cancer, androgen deprivation therapy, hypogonadism and estradiol. Studies were limited to those published in English and studies in men. In addition, pertinent review articles were searched for additional...
  2. Research:
    • Shuk-Mei Ho,
    • Rahul Rao,
    • Sarah To,
    • Emma Schoch,
    • and Pheruza Tarapore
    Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer Endocr Relat Cancer 24 (2) 83-96, doi:10.1530/ERC-16-0175 first published on 20 December 2016
    ...is being replaced by these compounds in BPA-free consumer products. We have previously shown that chronic and developmental exposure to BPA is associated with increased prostate cancer (PCa) risk in human and animal models. Here, we examine whether exposure of PCa cells (LNCaP, C4-2) to low-dose BPA...
  3. Review:
    • Sangeeta Kumari,
    • Dhirodatta Senapati,
    • and Hannelore V Heemers
    Rationale for the development of alternative forms of androgen deprivation therapy Endocr Relat Cancer 24 (8) R275-R295, doi:10.1530/ERC-17-0121 first published on 31 May 2017
    ...) Abstract With few exceptions, the almost 30,000 prostate cancer deaths annually in the United States are due to failure of androgen deprivation therapy. Androgen deprivation therapy prevents ligand-activation of the androgen receptor. Despite initial remission after androgen deprivation therapy, prostate...
  4. Thematic Review:
    • Carolyn A Allan,
    • Veronica R Collins,
    • Mark Frydenberg,
    • Robert I McLachlan,
    • and Kati L Matthiesson
    Androgen deprivation therapy complications Endocr Relat Cancer 21 (4) T119-T129, doi:10.1530/ERC-13-0467 first published on 28 May 2014
    .... Medical Journal of Australia 184 176–179. Hussain SA, Weston R, Stephenson RN, George E & Parr NJ 2003 Immediate dual energy X-ray absorptiometry reveals a high incidence of osteoporosis in patients with advanced prostate cancer before hormonal manipulation. BJU International 92 690–694. (doi:10.1046/ j...
  5. Research:
    • Willemijn A van Gemert,
    • Evelyn M Monninkhof,
    • Anne M May,
    • Sjoerd G Elias,
    • Job van der Palen,
    • Wouter Veldhuis,
    • Maaike Stapper,
    • Rebecca K Stellato,
    • Jantine A Schuit,
    • and Petra H Peeters
    Association between changes in fat distribution and biomarkers for breast cancer Endocr Relat Cancer 24 (6) 297-305, doi:10.1530/ERC-16-0490 first published on 16 May 2017
    ...://.endocrinology-journals.org © 2017 Society for Endocrinology Printed in Great Britain Published by Bioscientifica Ltd. 24:6 Fat measurements (determinant) At the baseline and after 16  weeks, body fat and lean mass were assessed by whole body dual energy X-ray absorptiometry (DEXA, Lunar Prodigy). Abdominal fat, comprising...
  6. Review:
    • Niamh L Mundell,
    • Robin M Daly,
    • Helen Macpherson,
    • and Steve F Fraser
    Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise training Endocr Relat Cancer 24 (4) R145-R155, doi:10.1530/ERC-16-0493 first published on 16 February 2017
    ...deterioration in Endocrine-Related Cancer (2017) 24, R145–R155 244 R145–R155 Correspondence should be addressed to N L Mundell Email niamh.mundell@deakin. edu.au Key Words f exise f cognitive function f prostate cancer f androgen deprivation therapy R146Review N L Mundell et al. A potential role for exise...
  7. Research:
    • Thine Hvid,
    • Kamilla Winding,
    • Anders Rinnov,
    • Thomas Dejgaard,
    • Carsten Thomsen,
    • Peter Iversen,
    • Klaus Brasso,
    • Kari J Mikines,
    • Gerrit van Hall,
    • Birgitte Lindegaard,
    • Thomas P J Solomon,
    • and Bente K Pedersen
    Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy Endocr Relat Cancer 20 (5) 621-632, doi:10.1530/ERC-12-0393 first published on 6 June 2013
    ...mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. Journal of Urology 167 2361–2367. (doi:10.1016/S0022-5347(05)64985-3) Boettcher M, Machann J, Stefan N...
  8. Review:
    • Gido Snaterse,
    • Jenny A Visser,
    • Wiebke Arlt,
    • and Johannes Hofland
    Circulating steroid hormone variations throughout different stages of prostate cancer Endocr Relat Cancer 24 (11) R403-R420, doi:10.1530/ERC-17-0155 first published on 18 September 2017
    .... 24:11 modalities of PC. While efforts have been undertaken to include data on all stages and modalities, most findings in literature report serum steroids levels in the treatmentnaïve stage of prostate cancer, after treatment with androgen deprivation therapy and/or abiraterone with prednisone. Thus...
  9. Review:
    • Melissa Gamat and
    • Douglas G McNeel
    Androgen deprivation and immunotherapy for the treatment of prostate cancer Endocr Relat Cancer ERC-17-0145, doi:10.1530/ERC-17-0145 first published on 16 August 2017
    ...). Androgen deprivation therapy (ADT), using 46 surgical or chemical castration, is a standard treatment used in all stages of recurrent prostate cancer. 47 Eventually patients will develop castration-resistant prostate cancer (CRPC) prompting additional 48 therapies, many of which further block the androgen...
  10. Review:
    • Ada S Cheung,
    • Jeffrey D Zajac,
    • and Mathis Grossmann
    Muscle and bone effects of androgen deprivation therapy: current and emerging therapies Endocr Relat Cancer 21 (5) R371-R394, doi:10.1530/ERC-14-0172 first published on 23 July 2014
    ...-Related Cancer (2014) 21, R371–R394Abstract Prostate cancer and treatment with androgen deprivation therapy (ADT) affect significant numbers of the male population. Endocrine effects of ADT are a critical consideration in balancing the benefits and risks of treatment on long-term survival and quality of life...
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. November 2017, 24 (11)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most